Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Macrophage activation syndrome
hemophagocytic lymphohistiocytosis
interferon-γ
interleukin-18
interleukin-6
Journal
Immunological medicine
ISSN: 2578-5826
Titre abrégé: Immunol Med
Pays: England
ID NLM: 101736847
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
pubmed:
14
5
2021
medline:
14
1
2022
entrez:
13
5
2021
Statut:
ppublish
Résumé
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of systemic juvenile idiopathic arthritis (s-JIA). An immunological feature is the excessive activation and proliferation of T lymphocytes and macrophages. Massive hypercytokinemia is strongly associated with its pathogenesis, particularly the overproduction of interleukin (IL)-1, IL-6 and IL-18; interferon (IFN)-γ; and tumor necrosis factor (TNF)-α. Furthermore, heterozygous mutations in causative genes for primary hemophagocytic lymphohistiocytosis and
Identifiants
pubmed: 33982649
doi: 10.1080/25785826.2021.1912893
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM